sgusers7的部落格

NEW YORK, Oct.迷你倉 28, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:Dementia Global Clinical Trials Review, H2, 2013 .reportlinker.com/p0681717/Dementia-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=TherapyDementia Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Dementia Global Clinical Trials Review, H2, 2013" provides data on the Dementia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dementia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dementia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesTable of ContentsTable of Contents 2List of Tables 4List of Figures 5Introduction 6Dementia 6Report Guidance 6Clinical Trials by Region 7Clinical Trials by Country 8Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10Top Five Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Top Countries Contributing to Clinical Trials in Middle East and Africa 13Top Five Countries Contributing to Clinical Trials in Central and South America 14Clinical Trials by BRIC Nations 15Clinical Trials by G7 Nations 16Clinical Trials in G7 Nations by Trial Status 17Clinical Trials by E7 Nations 18Clinical Trials in E7 Nations by Trial Status 19Clinical Trials by Phase 20In Progress Trials by Phase 21Clinical Trials by Trial Status 22Unaccomplished Trials of Dementia 23Subjects Recruited Over a Period of Time 26Prominent Sponsors 27Top Companies Participating in Dementia Therapeutics Clinical Trials 29Prominent Drug Comparison 31Clinical Trial Profiles 32Clinical Trial Overview of Top Companies 32Johnson & Johnson 32Clinical Trial Overview of Johnson & Johnson 32Eisai Co., Ltd. 35Clinical Trial Overview of Eisai Co., Ltd. 35Novartis AG 37Clinical Trial Overview of Novartis AG 37Pfizer Inc. 39Clinical Trial Overview of Pfizer Inc. 39H. Lundbeck A/S 40Clinical Trial Overview of H. Lundbeck A/S 40Teva Pharmaceutical Industries Limited 41Clinical Trial Overview of Teva Pharmaceutical Industries Limited 41Forest Laboratories, Inc. 42Clinical Trial Overview of Forest Laboratories, Inc. 42Eli Lilly and Company 43Clinical Trial Overview of Eli Lilly and Company 43Merck & Co., Inc. 44Clinical Trial Overview of Merck & Co., Inc. 44Bristol-Myers Squibb Company 45Clinical Trial Overview of Bristol-Myers Squibb Company 45Clinical Trial Overview of Top Institutes / Government 46U.S. Department of Veterans Affairs 46Clinical Trial Overview of U.S. Department of Veterans Affairs 46VU University Medical Center 47Clinical Trial Overview of VU University Medical Center 47National Institute of Mental Health 48Clinical Trial Overview of National Institute of Mental Health 48National Institute of Neurological Disorders and Stroke 49Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 49Sykehuset Innlandet HF 50Clinical Trial Overview of Sykehuset Innlandet HF 50National Institute on Aging 51Clinical Trial Overview of National Institute on Aging 51Radboud University 52Clinical Trial Overview of Radboud University 52University of California, San Francisco 53Clinical Trial Overview of University of California, San Francisco 53Penn State University 54Clinical Trial Overview of Penn State University 54Samsung Medical Center 55Clinical Trial Overview of Samsung Medical Center 55Five Key Clinical Profiles 56Appendix 111Abbreviations 111Definitions 111Research Methodology 112Secondary Research 112About GlobalData 113Contact Us 113Disclaimer 113Source 114List of TablesDementia Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7Dementia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8Dementia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9Dementia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10Dementia Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11Dementia Therapeutics Clinical Trials, North America, mini storageop Countries, 2013* 12Dementia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13Dementia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14Dementia Therapeutics Clinical Trials, BRIC Countries, 2013* 15Dementia Therapeutics Clinical Trials, G7 Countries, 2013* 16Dementia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17Dementia Therapeutics Clinical Trials, E7 Countries, 2013* 18Dementia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19Dementia Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20Dementia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21Dementia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22Dementia Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23Dementia Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 23Dementia Therapeutics Market, Global, Terminated Clinical Trials, 2013* 24Dementia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26Dementia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28Dementia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30Dementia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 32Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2013* 35Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 37Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 39Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2013* 40Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 41Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 42Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 43Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 44Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 45Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 46Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2013* 47Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2013* 48Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2013* 49Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sykehuset Innlandet HF, 2013* 50Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2013* 51Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2013* 52Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 53Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Penn State University, 2013* 54Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2013* 55List of FiguresDementia Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7Dementia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8Dementia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9Dementia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10Dementia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11Dementia Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12Dementia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13Dementia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14Dementia Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15Dementia Therapeutics Clinical Trials, G7 Countries (%), 2013* 16Dementia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17Dementia Therapeutics Clinical Trials, E7 Countries (%), 2013* 18Dementia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19Dementia Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20Dementia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21Dementia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22Dementia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26Dementia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 27Dementia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 29Dementia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31GlobalData Methodology 112To order this report: Dementia Global Clinical Trials Review, H2, 2013 .reportlinker.com/p0681717/Dementia-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy__________________________Contact Clare: clare@reportlinker.com US: (339)-368-6001Intl: +1 339-368-6001ReportlinkerWeb site: .reportlinker.com/儲存